These final results, together with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 support the strategy of focusing on ACKR3 as a unique approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant Issues. Importantly, these receptors https://elbertb789kyk6.wiki-racconti.com/user